The Critical Need for AI Literacy in Pharma Leadership
We’ve said it before, in our article Hybrid Intelligence: How AI roles can lead to commercial success (or failure), “What’s important to understand is that AI project failure doesn’t occur in a vacuum. People are more than just secondary considerations to hardware and software when it comes to AI — the reason things don’t work out as they should is almost always down to human rather than technical failure.”
Why is AI literacy so critical for pharma leadership?
Making people primary considerations in pharma’s use of artificial intelligence (AI) involves ensuring AI literacy in leadership and across boards, not just in our technical managers and data scientists. The lack of AI literacy in leadership sits behind the reasons why most AI initiatives fail. AI literacy in leaders– especially in non-technical leaders – also powers AI success. We need AI literacy in the C-suite to develop strategic initiatives that have the potential to succeed to move the needle on real world impact from AI initiatives.
The staggering statistics: AI initiatives usually fail
It’s nothing new, and we’re already too immune to the fact, but most AI initiatives fail.
As Gartner revealed, as far back as 2018, “85% of AI projects will “deliver erroneous outcomes.” Other surveys and reports come out with similar statistics with the failure rate of AI projects between 83% and 92%. The fact that only two out of five businesses report gains from their AI investments reflects this. A mere 13% of data science projects making it into production provides evidence of this too. The global AI pharma market expects to reach $3,624.24 million in 2026. That’s a shocking waste of money if we continue with such high failure rates.
C suites know they want and need artificial intelligence in their pharma businesses – so they are spending so heavily. They know it has the potential to transform their future success and deliver unrivalled competitive advantage. So they throw money at AI, believing that simply doing so will lead to pharma success. But when seven out of 10 executives who have invested in AI report they’ve seen minimal or no impact, and failure rates are so painfully high, what’s going wrong?
Why do AI projects fail?
There are multiple reasons cited for the lack of consistent AI project success. Each of these reasons holds merit. However, one overriding factor behind each of these reasons is low AI literacy at the pharma board and executive leadership level. In contrast, the need for AI literacy amongst this population is high. Pharma leaders need to understand AI far, far better than they currently do.
Let’s look at some common reasons why artificial intelligence projects in pharma tend to fail and how those reasons wouldn’t be present if there were greater AI literacy at the leadership level.
· AI initiatives are oversold
It’s easy to oversell AI solutions because of the temptation to think of AI as magic. We can blame vendors of AI solutions for pharma for stating that their platform does more than it does when in reality, the pharma leaders didn’t understand its capabilities and expected more than it could deliver.
How AI literacy in leadership would eliminate this: A clued-up C-suite won’t fall foul of seeing AI solutions as magic if they understand enough about how and why AI solutions work. They won’t fall for the sales spin but will have realistic expectations.
· Data isn’t understood as the bedrock
Any AI solution is only as good as the data it sits on. Even the most technically capable AI solution appropriately utilised won’t deliver if the data behind it is poor. The big whammy of AI project success is clean, accurate, prolific, and mineable data.
How AI literacy in leadership would eliminate this: Right now, even understanding that the data is everything is missing from leadership understanding. AI literacy gives data the importance it needs in any AI project. Beyond this, leadership should have the ability and foresight to conduct a data audit and feasibility study first.
· The solution is seen as more important than the strategy
The belief that AI is magic is tied closely to the idea that it can solve all problems. Often AI projects are approached with shiny things disease rather than identifying the problem first. It’s why an AI blueprint is so important; the solution should first solve a defined problem identified from wider business conundrums. Without this, AI developers and vendors create solutions that fix their perceived understanding of your problem rather than meet the objective and desired outcome.
How AI literacy in leadership would eliminate this: AI literate leaders understand the importance of defining the problem that needs solving so that objectives are clearly understood. They can communicate expectations clearly to the AI development team because they know enough about the capability of AI, but importantly, they understand enough about the presenting corporate challenges that need to be solved.
· There’s a misunderstanding about who does what
Developing AI solutions is like a newborn baby regarding organisational structure because we don’t have a set format for who does what on AI projects, and we’re still learning. At best, we approach it as another IT project, which is woefully short of what it is. As such, projects flounder across silos. No one talks to anyone else because they don’t even realise they should.
How AI literacy in leadership would eliminate this: An AI literate C suite would stop the silo effect in artificial intelligence projects because it would see the need for a dedicated and collaborative team that pulls together the full spectrum of skills and know-how in a perfect blend. Like we know the different components of an effective clinical research team because we’ve been using them for decades, AI literacy would allow boards to understand how to create effective AI project teams.
· Underestimating what needs to happen for AI buy-in
It’s one thing to develop an AI solution, but it’s another to get your people to use it. It may be all-singing-all-dancing, but it’ll fail if your people aren’t on board culturally. Partly this is a matter of training and talent acquisition, and partly it’s a matter of cultural shift.
How AI literacy in leadership would eliminate this: Leaders well versed in AI literacy know that this is a problem and head it off by effecting cultural shifts from the top and underpinning the importance of understanding for all. Leaders must remove the black box effect from AI implementation, whereby users don’t understand why the solution works and become suspicious of it.
What does AI literacy look like for leadership?
No one is expecting pharma leaders to become experts in developing AI solutions. We don’t expect C suites and executive leadership in pharma to know their Generative Adversarial Networks (GANs) from their dimensionality reductions. They don’t need to know anything about Python, Lisp, Java, Julia or even Haskell.
However, pharma leaders will benefit from becoming AI literate and becoming experts in how to get what they need from AI vendors, data scientists and the like. This means knowing about AI capability – they need to understand how and why AI works. AI literacy involves knowing why an AI strategic blueprint is essential and how to create one. Furthermore, with AI literacy, leaders must understand why and how AI is already succeeding and how to mirror that within their business for their own specific strategic challenges and objectives. It involves understanding the data available and the problems that need fixing. Finally, it includes understanding how AI fits in with broader business goals.
Recommended by LinkedIn
Conclusion
AI literacy will enable pharma leaders to become the expert AI strategists they need to be. It allows AI for pharma success in several core ways:
· It helps determine the AI initiatives that will move the needle on real-world impact for the company.
· It targets AI projects with the strongest strategic alignment, cost/benefit ratio and those offering a greater chance of success.
· It helps set realistic expectations.
· It determines that AI projects get what they need to succeed.
P.S. Here are 6 ways we can help you accelerate your Pharma AI results:
Dr Bates posts regularly about AI in Pharma so if you follow her you will get even more insights.
Our 2025 Masterclasses are now available for enrolment. Sign up now to get the Earlybird discount!
Revolutionize your team’s AI solution vendor choice process and unlock unparalleled efficiency and save millions on poor AI vendor choices that are not meeting your needs! Stop wasting precious time sifting through countless vendors and gain instant access to a curated list of top-tier companies, expertly vetted by leading pharma AI experts.
Every year, we rigorously interview thousands of AI companies that tackle pharma challenges head-on. Our comprehensive evaluations cover whether the solution delivers what is needed, their client results, their AI sophistication, cost-benefit ratio, demos, and more. We provide an exclusive, dynamic database, updated weekly, brimming with the best AI vendors for every business unit and challenge. Plus, our cutting-edge AI technology makes searching it by business unit, challenge, vendors or demo videos and information a breeze.
Transform your AI strategy with our expertly curated vendors that walk the talk, and stay ahead in the fast-paced world of pharma AI!
Get on the wait list to access this today. Click here.
When we analysed the most successful AI in biopharma and their agencies, we found there are very specific strategies that deliver the most consistent results year after year. This assessment is designed to give clarity as to how to achieve a successful outcome from AI.
The first step is to complete this short questionnaire, it will give us the information to assess which process is right for you as a next step.
It’s free and obligation-free, so go ahead and complete it now. Plus receive a free link to our a free AI tools pdf and our 5 day training (30 mins a day) in AI in pharma. Link to assessment here.
We have created an in-depth on-demand training about AI specifically for pharma that translate it into easy understanding of AI and how to apply it in all the different pharma business units — Click here to find out more.
This is a critical discussion. The high failure rates highlight the need for a strategic approach to AI rather than just jumping on the trend. What do you think would be the first steps for leadership to enhance their AI literacy?
Transforming Pharma through Digital Strategy | Co-Founder, NicEye Group | Innovation Advocate
1moInsightful 🙌
Bio/pharma system regulatory compliance | 21 CFR Part 11, Annex 11, data integrity | quality assurance, implementation, validation, management | on-premise, cloud (SaaS, IaS) | vendor audits
2moIn some sense, AI is no different than any other automated solution. Problem definition, well-defined requirements, fitting the right solution to the right problem, and organizational change management with good communication and end user buy-in are necessary components for all technology projects. Certainly, AI has its nuances that are different, as with most new technology, but the basics for good systems implementation still apply.
Data Warehouse Records Quality SME
2moAn ML system developer, as an example of an AI application, is a true polymath, an expert in data science, computer science, mathematics, and statistics. In the world of computer science, there are no miracles. The success of an ML application is not a matter of chance but of the skilled developer's expertise, the quality of the data they work with, and the diligent monitoring and maintenance of the model.
BUILD AI product and OPERATIONALIZE analytics outcomes into concrete action plan to drive $ impact and patients treated
2moFully agree with what you said. Ai is a mean to an end that when successful allow for better decision and better outcomes. Technology and tool enables process. But in the case of Ai it happens that the tool shape us more than we shape the tool. To be successful leadership need to remain in the driving sit and properly prioritize and ensure integration in ways of working.